277 related articles for article (PubMed ID: 22115164)
1. Prolactinoma in pregnancy.
Molitch ME
Best Pract Res Clin Endocrinol Metab; 2011 Dec; 25(6):885-96. PubMed ID: 22115164
[TBL] [Abstract][Full Text] [Related]
2. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
[TBL] [Abstract][Full Text] [Related]
3. Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma.
Molitch ME
Eur J Endocrinol; 2015 May; 172(5):R205-13. PubMed ID: 25805896
[TBL] [Abstract][Full Text] [Related]
4. Management of prolactinomas during pregnancy.
Molitch ME
J Reprod Med; 1999 Dec; 44(12 Suppl):1121-6. PubMed ID: 10649822
[TBL] [Abstract][Full Text] [Related]
5. Prolactinoma and pregnancy: From the wish of conception to lactation.
Maiter D
Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
[TBL] [Abstract][Full Text] [Related]
6. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation.
Auriemma RS; Perone Y; Di Sarno A; Grasso LF; Guerra E; Gasperi M; Pivonello R; Colao A
J Clin Endocrinol Metab; 2013 Jan; 98(1):372-9. PubMed ID: 23162092
[TBL] [Abstract][Full Text] [Related]
7. Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
Colao A; Di Sarno A; Guerra E; De Leo M; Mentone A; Lombardi G
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):200-10. PubMed ID: 16932285
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.
Rastogi A; Bhadada SK; Bhansali A
Gynecol Endocrinol; 2017 Apr; 33(4):270-273. PubMed ID: 27908214
[TBL] [Abstract][Full Text] [Related]
9. [Prolactinoma and pregnancy].
Trifonov I
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():16-22. PubMed ID: 15518268
[No Abstract] [Full Text] [Related]
10. Management of prolactinomas during pregnancy.
Witek P; Zieliński G
Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
[TBL] [Abstract][Full Text] [Related]
11. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
Lebbe M; Hubinont C; Bernard P; Maiter D
Clin Endocrinol (Oxf); 2010 Aug; 73(2):236-42. PubMed ID: 20455894
[TBL] [Abstract][Full Text] [Related]
12. [Management of prolactinomas during pregnancy].
Chen W; Bian X; Gai M; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):335-7. PubMed ID: 12126566
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.
Bahceci M; Sismanoglu A; Ulug U
Gynecol Endocrinol; 2010 Jul; 26(7):505-8. PubMed ID: 20459348
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
Liu C; Tyrrell JB
Pituitary; 2001 Aug; 4(3):179-85. PubMed ID: 12138991
[TBL] [Abstract][Full Text] [Related]
15. Update on prolactinomas. Part 2: Treatment and management strategies.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
[TBL] [Abstract][Full Text] [Related]
16. Prolactinomas and pregnancy.
Bronstein MD
Pituitary; 2005; 8(1):31-8. PubMed ID: 16411066
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia: pathophysiology and management.
Verhelst J; Abs R
Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy and Tumor Outcomes in Women with Prolactinoma.
Araujo B; Belo S; Carvalho D
Exp Clin Endocrinol Diabetes; 2017 Nov; 125(10):642-648. PubMed ID: 28704852
[No Abstract] [Full Text] [Related]
19. [Update on endocrinology: management of prolactinomas during pregnancy].
Cecenarro LA; Estario P; Estario ME; Fux-Otta C
Rev Fac Cien Med Univ Nac Cordoba; 2015; 72(3):170-4. PubMed ID: 26913801
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonists and pituitary tumor shrinkage.
Bevan JS; Webster J; Burke CW; Scanlon MF
Endocr Rev; 1992 May; 13(2):220-40. PubMed ID: 1352243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
